# An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

> clinical trial · VERIFIED · 2026-06-26

Status: RECRUITING · Sponsor: Liquidia Technologies, Inc. · Condition: Pulmonary Hypertension

- Company: Liquidia Technologies, Inc.
- Sector: cardiology
- Primary source: https://clinicaltrials.gov/study/NCT06129240

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.